Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ES cells for troubled hearts

Nature Biotechnology volume 25, pages 993–994 (2007)Cite this article

Cardiomyocytes derived from human embryonic stem cells prove beneficial in an animal model of myocardial infarction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Requisite steps for cardiac repair using hES cell–derived cardiomyocytes.

Katie Ris-Vicari

References

  1. Rubart, M. & Field, L.J. Annu. Rev. Physiol. 68, 29–49 (2006).

    Article  CAS  Google Scholar 

  2. Laflamme, M.A. et al. Nat. Biotechnol. 25, 1015–1024 (2007).

    Article  CAS  Google Scholar 

  3. American Heart Association/American Stroke Association. Heart Disease and Stroke Statistics: 2007 Update <http://www.americanheart.org/downloadable/heart/1166711577754HS_StatsInsideText.pdf>.

  4. Weir, R.A. & McMurray, J.J. Curr. Heart Fail. Rep. 3, 175–180 (2006).

    Article  Google Scholar 

  5. van Laake, L.W. et al. Stem Cell Res. (in the press) 10.1016/j.scr.2007.06.001 (2007).

  6. Gaudesius, G., Miragoli, M., Thomas, S.P. & Rohr, S. Circ. Res. 93, 421–428 (2003).

    Article  CAS  Google Scholar 

  7. Kaab, S. et al. Circ. Res. 78, 262–273 (1996).

    Article  CAS  Google Scholar 

  8. Rubart, M. et al. Circ. Res. 92, 1217–1224 (2003).

    Article  CAS  Google Scholar 

  9. Huber, I. et al. FASEB J. 21, 2551–2563 (2007).

    Article  CAS  Google Scholar 

  10. Anderson, D. Mol. Ther. (in the press) (2007).

  11. Schroeder, M. et al. Biotechnol. Bioeng. 92, 920–933 (2005).

    Article  CAS  Google Scholar 

  12. Laflamme, M.A. et al. Am. J. Pathol. 167, 663–671 (2005).

    Article  CAS  Google Scholar 

  13. Kattman, S.J., Huber, T.L. & Keller, G.M. Dev. Cell 11, 723–732 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Cardiology and Krannert Institute of Cardiology, Michael Rubart and Loren Field are at the Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana 46202-5225 USA. mrubartv@iupui.edu ljfield@iupui.edu,

    Michael Rubart & Loren J Field

Authors
  1. Michael Rubart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loren J Field
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Loren Field has patents for use of ES-derived myocytes for cardiac repair.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubart, M., Field, L. ES cells for troubled hearts. Nat Biotechnol 25, 993–994 (2007). https://doi.org/10.1038/nbt0907-993

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0907-993

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing